Abeona Therapeutics: ZEVASKYN Data Key In Gauging Momentum - Why I Hold [Seeking Alpha]
Abeona Therapeutics Inc. (ABEO)
Last abeona therapeutics inc. earnings: 3/16 04:20 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.abeonatherapeutics.com
Company Research
Source: Seeking Alpha
ZEVASKYN, a one-time gene therapy for severe skin disorder, faces execution risks but offers potential market share versus established competitor Vyjuvek. ABEO maintains a strong cash position with over two years of runway, but profitability depends on scaling patient treatments and overcoming manufacturing and regulatory hurdles. Despite a discounted valuation and strong analyst ratings, I rate ABEO as HOLD until Q3 results clarify ZEVASKYN's commercial traction and patient conversion rates. Jacob Wackerhausen/iStock via Getty Images Abeona Therapeutics Inc. (NASDAQ: ABEO ) stock has had a bad year so far after tumbling by double-digit figures. The stock is currently trading near its 52-week lows potentially offering perfect entry points. The company is at This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wro
Show less
Read more
Impact Snapshot
Event Time:
ABEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABEO alerts
High impacting Abeona Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ABEO
News
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead [Seeking Alpha]Seeking Alpha
- Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates [Yahoo! Finance]Yahoo! Finance
- Abeona Therapeutics GAAP EPS of -$0.10 beats by $0.18 [Seeking Alpha]Seeking Alpha
ABEO
Earnings
- 11/12/25 - Beat
ABEO
Analyst Actions
- 10/13/25 - HC Wainwright
ABEO
Sec Filings
- 11/14/25 - Form 4
- 11/13/25 - Form SCHEDULE
- 11/12/25 - Form 10-Q
- ABEO's page on the SEC website